Recombinant Human CCPG1 Protein, N-His from ProteoGenix; catalogue ARO-P10656; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Recombinant Human CCPG1 Protein is a highly purified and biologically active protein that is produced through recombinant DNA technology. This protein is an important antigen that plays a crucial role in various biological processes. In this article, we will discuss the structure, activity, and applications of Recombinant Human CCPG1 Protein.
Recombinant Human CCPG1 Protein is a 35 kDa protein that is composed of 316 amino acids. It has a unique structure consisting of a signal peptide, a propeptide, and a mature peptide. The signal peptide is responsible for targeting the protein to the endoplasmic reticulum, where it undergoes post-translational modifications. The propeptide is cleaved off during this process, resulting in the mature peptide that is responsible for the biological activity of the protein.
Recombinant Human CCPG1 Protein also contains several conserved domains, including a cysteine-rich domain, a glycosaminoglycan-binding domain, and a C-terminal domain. These domains play a crucial role in the function and activity of the protein.
Recombinant Human CCPG1 Protein is a multifunctional protein that has been shown to have various activities in different biological processes. It is primarily known for its role in cell adhesion and migration. It has been shown to interact with different extracellular matrix proteins, such as fibronectin and laminin, and promote cell adhesion and migration.
In addition to its role in cell adhesion, Recombinant Human CCPG1 Protein also has anti-angiogenic properties. It inhibits the formation of new blood vessels, which is crucial in various diseases, such as cancer and diabetic retinopathy.
Moreover, Recombinant Human CCPG1 Protein has been shown to have anti-inflammatory properties. It can inhibit the production of pro-inflammatory cytokines and chemokines, thus reducing inflammation in various diseases.
Due to its diverse activities, Recombinant Human CCPG1 Protein has a wide range of applications in the field of biomedicine. One of its primary applications is in tissue engineering. It can be used to promote cell adhesion and migration, which is crucial in tissue regeneration and repair.
Recombinant Human CCPG1 Protein also has potential therapeutic applications in various diseases. Its anti-angiogenic and anti-inflammatory properties make it a promising candidate for the treatment of cancer, diabetic retinopathy, and other inflammatory diseases.
Furthermore, Recombinant Human CCPG1 Protein has been shown to have potential diagnostic applications. It can be used as a biomarker for certain diseases, as its levels have been found to be altered in various pathological conditions.
In conclusion, Recombinant Human CCPG1 Protein is a highly purified and biologically active protein with a unique structure and diverse activities. It has potential applications in tissue engineering, therapeutics, and diagnostics. Further research on this protein can lead to a better understanding of its role in various biological processes and its potential use in the treatment of diseases.
ProteoGenix catalogue number ARO-P10656. For research use only.
Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 16.27 kDa; Fragment: Asn621-Gly735; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
